Skip to content

DOV vs JNJ: Dividend Comparison

DOV$231.16
DOVER Corp
Industrials
vs
JNJ$243.53
Johnson & Johnson
Health Care

Dividend data as of

DOVER Corp (DOV) from Industrials and Johnson & Johnson (JNJ) from Health Care offer different dividend profiles for income-focused portfolios. JNJ offers a significantly higher 2.16% yield compared to DOV's 0.90%, a gap of 1.26%. For dividend growth, JNJ leads with a 5-year CAGR of 5.2% versus DOV's 1.0%. Both stocks carry a "Safe" dividend safety rating. DOV is a Dividend Aristocrat while JNJ is a Dividend King.

Verdict

Best for Income
JNJ
Higher yield at 2.16%
Best for Growth
JNJ
5yr CAGR of 5.2%
Best for Safety
DOV
Lower payout ratio (26%)
Metric
Price
$231.16
$243.53
Dividend Yield
0.90%
2.16%
Annual Dividend
$2.08
$5.14
5yr Div CAGR
1.0%
5.2%
3yr Div CAGR
1.0%
4.6%
Consecutive Years
41
63
Payout Ratio
25.97%
46.60%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$90/yr
$216/yr

Yield Analysis

DOV
0.90%
JNJ
2.16%

JNJ yields 1.26% more than DOV. In dollar terms, DOV pays $2.08/share vs JNJ's $5.14/share annually.

Dividend Growth

DOV 5yr CAGR
1.0%
steady
JNJ 5yr CAGR
5.2%
decelerating

DOV: Dividend growth has been steady, with a 3-year CAGR of 1.0% and a 5-year CAGR of 1.0% (10-year: 4.5%).

JNJ: Dividend growth is slowing — the 3-year CAGR of 4.6% trails the 5-year rate of 5.2% and the 10-year rate of 5.6%.

Dividend Safety

DOV
Safe
Payout Ratio26%
JNJ
Safe
Payout Ratio47%

DOV: The payout ratio of 26% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 3.8x.

JNJ: The payout ratio of 47% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.1x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
DOV
JNJ
$10,000
$90/yr
$216/yr
$50,000
$450/yr
$1,078/yr
$100,000
$900/yr
$2,156/yr

What does $10,000 buy in DOV vs JNJ today?

At $231.16 per share, $10,000 buys about 43.3 shares of DOVER Corp (DOV). Each share pays $2.08 per year in dividends, so the position starts out generating roughly $90 per year — about $7 a month.

At $243.53 per share, $10,000 buys about 41.1 shares of Johnson & Johnson (JNJ). Each share pays $5.14 per year in dividends, so the position starts out generating roughly $211 per year — about $18 a month.

JNJ is the larger income stream from day one: $121 per year more on the same $10,000 invested.

What could $10,000 of DOV or JNJ income look like in 10 years?

DOVER Corp (DOV) has raised its dividend about 1.0% a year over the past five years. If that pace held, the $90 per year that $10,000 generates today at the current 0.90% yield would reach $99 per year by 2036 — a 1.0% yield on the original cost.

Johnson & Johnson (JNJ) has raised its dividend about 5.2% a year over the past five years. If that pace held, the $216 per year that $10,000 generates today at the current 2.16% yield would reach $359 per year by 2036 — a 3.6% yield on the original cost.

On those trailing rates, JNJ pays more in 2036: $359 versus $99 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would DOV's dividend growth overtake JNJ's higher yield?

It doesn't, on the trailing numbers. Johnson & Johnson (JNJ) yields more today (2.16% vs 0.90%) and has also grown its dividend at least as fast (5.2% vs 1.0% a year over five years). Unless DOV accelerates its raises or JNJ stumbles, DOV never closes the income gap — JNJ wins on both current income and growth.

Can DOV and JNJ afford their dividends?

DOVER Corp (DOV) earns $7.98 per share against $2.08 paid out in dividends — 3.8x coverage (a 26% payout ratio).

Johnson & Johnson (JNJ) earns $11.03 per share against $5.14 paid out in dividends — 2.1x coverage (a 47% payout ratio).

DOV's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for JNJ if earnings weaken.

Which fits an early-retirement income portfolio better, DOV or JNJ?

For income you need right now, Johnson & Johnson (JNJ) leads: $100,000 invested today pays about $180 a month at the current 2.16% yield, versus $75 a month from DOVER Corp (DOV) at 0.90%.

JNJ also leads on dividend growth (5.2% vs 1.0% a year over five years), so the trailing numbers favor it on both fronts.

On consistency: DOV has raised its dividend 41 consecutive years; JNJ has raised its dividend 63 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $109/yr in DOV vs $445/yr in JNJ by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Track DOV and JNJ in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan.

Choosing a tracker? See the best dividend trackers compared.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.